Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

Vaccine development has become the main tool for reducing COVID-19 cases and the severity of the disease. Comparative analyses of adaptive immunity generated by different vaccines platforms are urgently needed. Multiple studies have compared different vaccines using similar platforms; however, compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvan, Veronica, Quarleri, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691152/
https://www.ncbi.nlm.nih.gov/pubmed/34935099
http://dx.doi.org/10.1007/s11357-021-00501-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691152/
https://www.ncbi.nlm.nih.gov/pubmed/34935099
http://dx.doi.org/10.1007/s11357-021-00501-3

Ejemplares similares